glp 1 agents Glucagon-like peptide-1 GLP-1 RAs, Other Agents, Underused
Description
This analysis examines specific approaches to reduce GLP-1 medication costs, including manufacturer savings programs, prescription assistance options, and alternative procurement methods
P =0.03)
JAMA Network Open, 8(2), Article PMC12096058
& Amer, S
While all are approved for obesity treatment, evidence specifically in post-bariatric populations varies considerably
